ViewRay Appoints Scott Huennekens and Daniel Moore to its Board of Directors

New Directors Bring Extensive Medical Device Experience to the Board [07-February-2018] CLEVELAND, Feb. 7, 2018 /PRNewswire/ — ViewRay  (Nasdaq: VRAY), maker of the world’s first and only clinical MRI-guided radiation therapy system, announced today the appointment of medical device industry veterans Scott Huennekens and Daniel Moore to the Company’s board of directors, […]

Surefire Medical Names Former Novelion CEO as New Leader

DENVER–(BUSINESS WIRE)– Surefire Medical (Surefire) today announced the appointment of Mary T. Szela as its CEO, President, and a member of the company’s Board of Directors. Szela brings nearly 30 years of progressive leadership experience to Surefire building global billion-dollar brands, advancing pipeline products in the biotechnology, medical products, and pharmaceutical industries, […]

Bluegrass Vascular Announces Enrollment of First Patients in U.S. Pivotal Trial

SAN ANTONIO, Jan. 18, 2018 /PRNewswire/ — Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access, today announced the enrollment of its first patients in the SAVE-US (Surfacer® System to Facilitate Access in VEnous Occlusions – United States) pivotal trial. The SAVE-US clinical trial is a pre-market […]

Beverly A. Huss Joins Accuray Board of Directors

SUNNYVALE, Calif., Jan. 11, 2018 /PRNewswire/ — Accuray Incorporated (NASDAQ: ARAY) announced today the appointment of Beverly A. Huss to the company’s Board of Directors, effective January 7, 2018. Ms. Huss also currently serves on the boards of Qool Therapeutics, Inc., Surefire Medical, Inc., and Madorra. Her prior public company board experience includes Artes Medical, Wright […]

Guerbet announces its acquisition of Accurate Medical Therapeutics, an innovative company that develops microcatheters for interventional radiology

Villepinte (France), January 8, 2018 (17:45 CET) – Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, announced that it has entered into an agreement under which it will acquire Israeli company Accurate Medical Therapeutics (“Accurate”), which specializes in the development of microcatheters used in […]

Teleflex Surpasses 200,000 Successfully Reprocessed ClosureFast® Catheters

WAYNE, Pa.–(BUSINESS WIRE)– Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, today announced that more than 200,000 ClosureFast® Catheters have been successfully reprocessed by the company’s partner, Northeast Scientific, Inc. (NES), since NES received FDA clearance for reprocessing the popular vein ablation catheter in 2011. […]

Centerline Biomedical Completes Fifth Preclinical Study

CLEVELAND, Jan. 4, 2018 /PRNewswire/ — As Centerline Biomedical, Inc. prepares to meet with investors, strategic partners and companies in the healthcare industry during the JP Morgan Healthcare Conference, it successfully completed a fifth preclinical study at Cleveland Clinic facilities evaluating its surgical navigation system, IOPS, the Intra-Operative Positioning System. This study […]

Toshiba Medical Systems Officially Becomes Canon Medical Systems

TOKYO–(BUSINESS WIRE)– Canon Inc. and Canon Medical Systems Corporation today announced the official corporate name (trade name) change of Canon Group Company Toshiba Medical Systems Corporation to Canon Medical Systems Corporation (hereafter referred to as Canon Medical Systems). Since joining the Canon Group in December 2016, Canon Medical Systems has been undertaking the procedures for obtaining regulatory approval […]

BTG plc: Northwestern University Adopts Y90 TARE with TheraSphere® as First-Line Treatment for HCC

LONDON, December 12, 2017 /PRNewswire/ — BTG plc (LSE: BTG), a global specialist healthcare company, today announced that following positive results of its 15-year experience between 2003 and 2017 with TheraSphere®, Northwestern University, Illinois has adopted Y90 transarterial radioembolisation (TARE) with TheraSphere® as the primary trans-arterial loco-regional therapy (LRT) for patients with hepatocellular carcinoma (HCC) limited to the […]